KaloCyte has a total of 19 patents globally, out of which 1 patent has been granted. Of these 19 patents, more than 89% patents are active. United States of America seems to be the main focused R&D centre and also is the origin country of KaloCyte.
KaloCyte was founded in 2016. Kalocyte is a healthcare biotech company in the pre-clinical stage that offers artificial red blood cell substitutes for services linked to trauma care. The company creates a proven proof of concept for ErythroMer, a dried artificial red blood cell inspired by biology that is intended to be used in situations when stored red blood cells are hard to come by, unfavourable, or insufficient.
Do read about some of the most popular patents of KaloCyte which have been covered by us in this article and also you can find KaloCyte patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over KaloCyte patent portfolio.
How many patents does KaloCyte have?
KaloCyte has a total of 19 patents globally. These patents belong to 4 unique patent families. Out of 19 patents, 17 patents are active.
How Many Patents did KaloCyte File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | KaloCyte Applications Filed | KaloCyte Patents Granted |
2023 | 3 | 1 |
2022 | 8 | – |
2021 | 8 | – |
How many KaloCyte patents are Alive/Dead?
Worldwide Patents
How Many Patents did KaloCyte File in Different Countries?
Countries in which KaloCyte Filed Patents
Country | Patent |
United States Of America | 2 |
Mexico | 2 |
Australia | 2 |
Brazil | 2 |
Canada | 2 |
South Africa | 2 |
Japan | 1 |
Europe | 1 |
Korea (South) | 1 |
Hong Kong (S.A.R.) | 1 |
India | 1 |
Where are Research Centers of KaloCyte Patents Located?
What Percentage of KaloCyte US Patent Applications Were Granted?
KaloCyte (Excluding its subsidiaries) has filed 2 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0%.
Below are the key stats of KaloCyte patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for KaloCyte?
Law Firm | Total Applications | Success Rate |
Whiteford Taylor & Preston Llp | 2 | 0% |
List of KaloCyte patents
KaloCyte Patents | Title |
US20220287984A1 | Compositions And Methods For Removing Bio-Synthetic Nano-Particles From Bodily Fluids |
US20210330754A1 | Self-Assembling Oxygen Carrier Compositions |
EP4138855A1 | Self-Assembling Oxygen Carrier Compositions |
CA3210619A1 | Compositions And Methods For Removing Bio-Synthetic Nano-Particles From Bodily Fluids |
CA3175425A1 | Self-Assembling Oxygen Carrier Compositions |
AU2022232631A1 | Compositions And Methods For Removing Bio-Synthetic Nano-Particles From Bodily Fluids |
AU2021261405A1 | Self-Assembling Oxygen Carrier Compositions |
JP2023523033A | Self-Assembling Oxygen Carrier Composition |
HK40085835A | Self-Assembling Oxygen Carrier Compositions |
BR112023018210A2 | Compositions And Methods For Removing Biosynthetic Nanoparticles From Body Fluids |
BR112022021291A2 | Self-Assembly Oxygen Vehicle Compositions |
IN202227060381A | Self-Assembling Oxygen Carrier Compositions |
ZA202211495B | Self-Assembling Oxygen Carrier Compositions |
MX2023010613A | Compositions And Methods For Removing Biosynthetic Nanoparticles From Body Fluids |
ZA202308676A | Compositions And Methods For Removing Bio-Synthetic Nano-Particles From Bodily Fluids |
KR1020230005285A | Self-Assembling Oxygen Carrier Composition |
MX2022013213A | Self-Assembled Oxygen Carrier Compositions |
WO2022192619A1 | Compositions And Methods For Removing Bio-Synthetic Nano-Particles From Bodily Fluids |
WO2021217010A1 | Self-Assembling Oxygen Carrier Compositions |
What are KaloCyte key innovation segments?
What Technologies are Covered by KaloCyte?
The chart below distributes patents filed by KaloCyte